Abstract
Background and aims
The information about clinical presentation and outcome of elderly hepatocellular carcinoma (HCC) patients is limited. We performed this study to assess the impact of age on potential differences in clinical characteristics, treatment patterns and outcome in HCC patients.
Methods
Clinical data of 164 “elderly” (≥70 years old) and 531 “younger” (<70 years old) HCC patients treated at a Chinese tertiary university-affiliated medical center between April 2004 and April 2012 were collected and compared using various parameters.
Results
Compared with younger patients, the elderly patients had a higher proportion of females (32.9 % vs. 18.1 %, p < 0.001), less hepatitis B virus (HBV) infection (40.9 % vs. 76.6 %, p < 0.001), more hepatitis C virus (HCV) infection (23.8 % vs. 5.6 %, p < 0.001), less liver cirrhosis (68.3 % vs. 76.8 %, p = 0.03) and massive tumors (12.8 % vs. 21.8 %, p = 0.01). There was no significant difference between the two groups in Child-Pugh class and tumor stages. The elderly patients received less surgical resection (14.6 % vs. 29.6 %, p < 0.001) and more supportive care (48.8 % vs. 37.9 %, p = 0.01) than younger patients. The overall survival was not significantly different between the two groups (26.2 mo. vs. 28.3 mo., p = 0.75).
Conclusion
Characteristics that distinguish elderly from younger HCC patients included more female, less HBV infection, more HCV infection, less liver cirrhosis and massive tumors. Significant differences were observed in therapeutic strategies utilized with the two groups, but the overall survival was not significantly different.
Similar content being viewed by others
References
Yang BH, Xia JL, Huang LW, Tang ZY, Chen MS, Li JQ, Liang AM, Mo QG, Lu HS, Dai CL, Yan LN, Yu ZJ, Rao RS, Li LQ, Su ZX, Fang ZW (2004) Changed clinical aspects of primary liver cancer in China during the past 30 years. Hepatobiliary Pancreat Dis Int 3(2):194–198
Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ (2006) The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 144(10):705–714
McGlynn KA, London WT (2005) Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 19(1):3–23. doi:10.1016/j.bpg.2004.10.004
Balducci L (2000) Geriatric oncology: challenges for the new century. Eur J Cancer 36(14):1741–1754
Kim YJ, Jang BK, Kim ES, Chung WJ, Park KS, Cho KB, Hwang JS (2012) Hepatocellular carcinoma in the elderly: clinical characteristics, treatment, survival analysis in Korean patients older than 70 years. J Korean Med Sci 27(10):1147–1154. doi:10.3346/jkms.2012.27.10.1147
Kozyreva ON, Chi D, Clark JW, Wang H, Theall KP, Ryan DP, Zhu AX (2011) A multicenter retrospective study on clinical characteristics, treatment patterns, and outcome in elderly patients with hepatocellular carcinoma. Oncologist 16(3):310–318. doi:10.1634/theoncologist.2010-0223
Pignata S, Gallo C, Daniele B, Elba S, Giorgio A, Capuano G, Adinolfi LE, De Sio I, Izzo F, Farinati F, Del Naja C, Stanzione M, Castiglione F, Marone G, Cuomo O, Felder M, Gaeta GB, De Maio E, Di Maio M, Signoriello G, Perrone F (2006) Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP). Crit Rev Oncol Hematol 59(3):243–249. doi:10.1016/j.critrevonc.2006.01.002
Ryder SD (2003) Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut 52(Suppl 3):iii1–iii8
Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5(6):649–655
Sheth M, Riggs M, Patel T (2002) Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC gastroenterology 2:2
Nzeako UC (1995) Etiologic factors and clinical presentation of hepatocellular carcinoma: differences between cirrhotic and noncirrhotic Italian patients. Cancer 76(5):915
Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P, Stefanini GF, Grazi G, Mazziotti A, Fornale L et al (1993) Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 72(5):1557–1563
Kudo M, Chung H, Osaki Y (2003) Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score). J Gastroenterol 38(3):207–215. doi:10.1007/s005350300038
Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19(3):329–338. doi:10.1055/s-2007-1007122
Manghisi G, Elba S, Mossa A, Giorgio A, Aloisio V, Perrotta A, Tardio B, Naja CD, Ca-turelli E, Calandra M, Castellano L, Sio ID (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients: the Cancer of the Liver Italian Program (CLIP) investigators. Hepatology 28(3):751–755. doi:10.1002/hep.510280322
Ramacciato G, Mercantini P, Cautero N, Corigliano N, Di Benedetto F, Quintini C, Ercolani G, Varotti G, Ziparo V, Pinna AD (2005) Prognostic evaluation of the new American Joint Committee on Cancer/International Union against Cancer staging system for hepatocellular carcinoma: analysis of 112 cirrhotic patients resected for hepatocellular carcinoma. Ann Surg Oncol 12(4):289–297. doi:10.1245/aso.2005.03.098
Namieno T, Kawata A, Sato N, Kondo Y, Uchino J (1995) Age-related, different clinicopathologic features of hepatocellular carcinoma patients. Ann Surg 221(3):308–314
Trevisani F, Cantarini MC, Labate AM, De Notariis S, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M (2004) Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival. Am J Gastroenterol 99(8):1470–1476. doi:10.1111/j.1572-0241.2004.30137.x
Mirici-Cappa F, Gramenzi A, Santi V, Zambruni A, Di Micoli A, Frigerio M, Maraldi F, Di Nolfo MA, Del Poggio P, Benvegnu L, Rapaccini G, Farinati F, Zoli M, Borzio F, Giannini EG, Caturelli E, Bernardi M, Trevisani F (2010) Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience. Gut 59(3):387–396. doi:10.1136/gut.2009.194217
Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT (2009) The outcomes of elderly patients with hepatocellular carcinoma treated with transarterial chemoembolization. Cancer 115(23):5507–5515. doi:10.1002/cncr.24636
Chang PE, Ong WC, Lui HF, Tan CK (2008) Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome. J Gastroenterol 43(11):881–888. doi:10.1007/s00535-008-2238-x
Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y, Furuta S, Akahane Y, Nishioka K, Purcell RH et al (1990) Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 12(4 Pt 1):671–675
Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, Bahar G, Sternov Y, Shpitzer T (2011) Squamous cell carcinoma of the oral tongue in patients over 75 years old. Aging Clin Exp Res 23(3):231–235
Llovet JM, Fuster J, Bruix J (2004) The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10(2 Suppl 1):S115–S120. doi:10.1002/lt.20034
Cantarini MC, Trevisani F, Morselli-Labate AM, Rapaccini G, Farinati F, Del Poggio P, Di Nolfo MA, Benvegnu L, Zoli M, Borzio F, Bernardi M (2006) Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma. Am J Gastroenterol 101(1):91–98. doi:10.1111/j.1572-0241.2006.00364.x
Anantharaju A, Feller A, Chedid A (2002) Aging liver. A review. Gerontology 48(6):343–353. doi:65506
Sarpel U, Ayo D, Lobach I, Xu R, Newman E (2012) Inverse relationship between cirrhosis and massive tumours in hepatocellular carcinoma. HPB (Oxford) 14(11):741–745. doi:10.1111/j.1477-2574.2012.00507.x
Huang J, Li BK, Chen GH, Li JQ, Zhang YQ, Li GH, Yuan YF (2009) Long-term outcomes and prognostic factors of elderly patients with hepatocellular carcinoma undergoing hepatectomy. J Gastrointest Surg 13(9):1627–1635. doi:10.1007/s11605-009-0933-4
Kaibori M, Matsui K, Ishizaki M, Saito T, Kitade H, Matsui Y, Kwon AH (2009) Hepatic resection for hepatocellular carcinoma in the elderly. J Surg Oncol 99(3):154–160. doi:10.1002/jso.21221
Ozenne V, Bouattour M, Goutte N, Vullierme MP, Ripault MP, Castelnau C, Valla DC, Degos F, Farges O (2011) Prospective evaluation of the management of hepatocellular carcinoma in the elderly. Dig Liver Dis 43(12):1001–1005. doi:10.1016/j.dld.2011.06.019
Thornton RH, Covey A, Petre EN, Riedel ER, Maluccio MA, Sofocleous CT, Brody LA, Getrajdman GI, D’Angelica M, Fong Y, Brown KT (2009) A comparison of outcomes from treating hepatocellular carcinoma by hepatic artery embolization in patients younger or older than 70 years. Cancer 115(21):5000–5006. doi:10.1002/cncr.24556
Conflict of interest
We declare that there is no conflict of interest. We have full control of all primary data and agree to allow the journal to review our data if requested.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, C., Jin, G., Sun, C. et al. Clinical characteristics, treatment patterns and survival outcome of hepatocellular carcinoma patients aged 70 years or older: a single-center retrospective study from China. Aging Clin Exp Res 26, 123–130 (2014). https://doi.org/10.1007/s40520-013-0142-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40520-013-0142-6